Half-Year 2022 Financial and Clinical Trials Update

cobas® HPV self-sampling solution Increasing screening adherence to potentially reach 1.7bn women globally Roche 342,000 women die per year of cervical cancer, ~90% in LMIC with majority unscreened 2 FASTER cobas® HPV self- sampling solution¹ cobas® HPV test CINtec Plus Cytology CINtec® Histology iThemba Life® Self sampling Screen Triage Diagnose Disease management New 90% correlation between clinician collected endocervical and self-collected vaginal specimens¹ LMICS-Low- and middle-income countries; HPV-Human papillomavirus; 1 Available in CE market; 2 www.unaids.org/en/cervical_cancer 43

View entire presentation